A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects

Completed · Phase 4

Conditions studied: Aspergillosis, Candidemia

In brief

The purpose of this study is to provide anidulafungin and voriconazole to healthy subjects to determine the drug concentration in the lung.

Key facts

Study ID

NCT00940017

Run by

Pfizer

People needed

24

Starts

2008-09-01

Expected to finish

2008-10-01

Last updated by the study team

2010-02-09

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adult subjects willing to comply with the study requirement.

You may not qualify if…

• Clinical significant disease.
• Sensitive to study medication.
• Not willing to comply with the study requirement.

Where it is running

• Pfizer Investigational Site — Hartford, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.